|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,874 |
$1,346,822.82 |
7.16% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,788 |
$1,344,899.68 |
7.15% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
14,477 |
$1,345,202.84 |
7.15% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
49,185 |
$1,232,576.10 |
6.55% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,812 |
$1,204,129.80 |
6.40% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
831 |
$852,007.68 |
4.53% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
4,093 |
$840,579.41 |
4.47% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,522 |
$757,661.10 |
4.03% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,048 |
$726,788.00 |
3.86% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,116 |
$712,541.84 |
3.79% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,557 |
$680,642.55 |
3.62% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,390 |
$673,857.80 |
3.58% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,363 |
$635,703.20 |
3.38% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
57,716 |
$618,715.52 |
3.29% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,893 |
$470,352.26 |
2.50% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
2,864 |
$404,024.48 |
2.15% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
3,034 |
$366,112.78 |
1.95% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
4,349 |
$327,479.70 |
1.74% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,081 |
$320,886.15 |
1.71% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
6,067 |
$252,690.55 |
1.34% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,493 |
$250,540.33 |
1.33% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
406 |
$239,576.54 |
1.27% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
9,430 |
$198,878.70 |
1.06% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
3,559 |
$194,784.07 |
1.04% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
2,317 |
$162,259.51 |
0.86% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
3,763 |
$155,261.38 |
0.83% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,144 |
$149,381.76 |
0.79% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,944 |
$139,093.20 |
0.74% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
948 |
$137,327.28 |
0.73% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
11,366 |
$132,300.24 |
0.70% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
3,446 |
$132,154.10 |
0.70% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
609 |
$117,670.98 |
0.63% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,404 |
$118,792.44 |
0.63% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,229 |
$115,980.73 |
0.62% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
561 |
$115,655.76 |
0.61% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
1,601 |
$106,290.39 |
0.57% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
513 |
$103,041.18 |
0.55% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
190 |
$100,549.90 |
0.53% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,140 |
$95,965.20 |
0.51% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,189 |
$89,817.06 |
0.48% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,827 |
$87,637.00 |
0.47% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
185 |
$83,094.60 |
0.44% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
1,837 |
$82,665.00 |
0.44% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,123 |
$80,227.12 |
0.43% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
804 |
$79,925.64 |
0.42% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,189 |
$76,599.78 |
0.41% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,296 |
$77,772.96 |
0.41% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,802 |
$74,719.12 |
0.40% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,093 |
$74,848.64 |
0.40% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
4,525 |
$62,354.50 |
0.33% |
| US Dollar |
$USD |
|
Other |
58,090 |
$58,090.17 |
0.31% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|